ADXN vs. SPY
ADXN (Addex Therapeutics Ltd) is a stock, while SPY (State Street SPDR S&P 500 ETF) is S&P 500 fund tracking the S&P 500 Index. Over the past 5 years, ADXN returned -51.66%/yr vs 12.76%/yr for SPY. Their 0.09 correlation means their historical movements had little consistent relationship.
Performance
ADXN vs. SPY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ADXN achieves a -32.64% return, which is significantly lower than SPY's 10.13% return.
ADXN
- 1D
- -7.06%
- 1M
- -10.19%
- 6M
- -32.11%
- YTD
- -32.64%
- 1Y
- -35.80%
- 3Y*
- -22.43%
- 5Y*
- -51.66%
- 10Y*
- —
- ALL TIME*
- -46.12%
SPY
- 1D
- 0.72%
- 1M
- 0.30%
- 6M
- 8.53%
- YTD
- 10.13%
- 1Y
- 21.49%
- 3Y*
- 19.32%
- 5Y*
- 12.76%
- 10Y*
- 15.07%
- ALL TIME*
- 10.79%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $6.50K | $8.48K | $18.95K | |
| $37.27B | $35.99B | $39.23B |
ADXN vs. SPY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
ADXN Addex Therapeutics Ltd | -32.64% | 10.29% | 15.70% | -51.99% | -89.98% | -53.06% | -7.59% |
SPY State Street SPDR S&P 500 ETF | 10.13% | 17.72% | 24.89% | 26.18% | -18.18% | 28.73% | 16.51% |
Correlation
The correlation between ADXN and SPY is 0.04, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.04 |
Correlation (3Y) Balances recent behavior with more history. | 0.10 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.09 |
Correlation (All Time) Calculated using the full available price history since Jan 29, 2020 | 0.09 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ADXN vs. SPY — Risk / Return Rank
ADXN
SPY
ADXN vs. SPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Addex Therapeutics Ltd (ADXN) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ADXN | SPY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.96 | ||
| Sortino ratioReturn per unit of downside risk | -2.31 | ||
| Omega ratioGain probability vs. loss probability | 0.98 | 1.27 | -0.30 |
| Calmar ratioReturn relative to maximum drawdown | -0.70 | 2.20 | -2.90 |
| Martin ratioReturn relative to average drawdown | -1.16 | 9.40 | -10.56 |
Loading charts...
Drawdowns
ADXN vs. SPY - Drawdown Comparison
The maximum ADXN drawdown since its inception was -98.94%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for ADXN and SPY.
Loading charts...
Drawdown Indicators
| ADXN | SPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.94% | -55.19% | -43.75% |
Max Drawdown (1Y)Largest decline over 1 year | -52.51% | -8.88% | -43.63% |
Max Drawdown (3Y)Largest decline over 3 years | -81.36% | -18.76% | -62.60% |
Max Drawdown (5Y)Largest decline over 5 years | -97.46% | -24.50% | -72.96% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.72% | — |
Current DrawdownCurrent decline from peak | -98.93% | -1.40% | -97.53% |
Average DrawdownAverage peak-to-trough decline | -82.41% | -9.01% | -73.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.60% | 2.08% | +29.52% |
Volatility
ADXN vs. SPY - Volatility Comparison
Addex Therapeutics Ltd (ADXN) has a higher volatility of 19.17% compared to State Street SPDR S&P 500 ETF (SPY) at 3.58%. This indicates that ADXN's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ADXN | SPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.17% | 3.58% | +15.59% |
Volatility (6M)Calculated over the trailing 6-month period | 48.67% | 10.14% | +38.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 84.22% | 12.89% | +71.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 111.17% | 17.18% | +93.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 121.32% | 17.95% | +103.37% |
Dividends
ADXN vs. SPY - Dividend Comparison
ADXN has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.01%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADXN Addex Therapeutics Ltd | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY State Street SPDR S&P 500 ETF | 1.01% | 1.07% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% |
Frequently Asked Questions
ADXN and SPY have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ADXN has higher volatility (19.17%) compared to SPY (3.58%). In terms of maximum drawdown, ADXN dropped -98.94% vs SPY's -55.19%.
SPY currently has the higher Sharpe Ratio (1.52 vs -0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ADXN and SPY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer